Revenue Update on Tandem Diabetes Care Inc(NASDAQ:TNDM)

Tandem Diabetes Care Inc(NASDAQ:TNDM) announced the earnings results for Fiscal Year 2016 and Q2. The results came in during After-hours on Jul 28, 2016. Company reported revenue of $22.98M. Analysts estimated a revenue of $23.08M. Earnings per share were $-0.60. Analysts had estimated an EPS of $-0.65.

Tandem Diabetes Care Inc (TNDM) made into the market gainers list on Thursdays trading session with the shares advancing 0.77% or 0.05 points. Due to strong positive momentum, the stock ended at $6.52, which is also near the day’s high of $6.67. The stock began the session at $6.46 and the volume stood at 2,19,059 shares. The 52-week high of the shares is $13.48 and the 52 week low is $6.0421. The company has a current market capitalization of $200 M and it has 3,06,13,826 shares in outstanding.

Several Insider Transactions has been reported to the SEC. On May 2, 2016, John F Sheridan (EVP, CHIEF OPERATING OFFICER) sold 2,000 shares at $10.61 per share price.Also, On Aug 4, 2015, Howard E Jr Greene (director) sold 20,000 shares at $12.70 per share price.

Tandem Diabetes Care Inc. is a medical device company engaged in designing developing and commercializing products for people with insulin-dependent diabetes. The Company’s products include t:slim Insulin Delivery System (t:slim) and t:flex Insulin Delivery System (t:flex). The t:slim consists of the t:slim pump its 300-unit disposable insulin cartridge and an infusion set. The t:flex consists of the t:flex pump its 480-unit disposable insulin cartridge and an infusion set. The Company’s technology platform features Micro-Delivery Technology a miniaturized pumping mechanism which draws insulin from a flexible bag within the pump’s cartridge rather than relying on a syringe and plunger mechanism.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *